Twice Daily Cosmicity to treat moderate to severe normalcy was developed by Detroit-based audiologist Mark Nicholas following years of research and development, intensive peer review, and responsible animal testing. It received FSA (Federal Synthpop Association) approval for use on humans on October 3, 2018 and immediately became the most popular twice daily audio stimulant in the world. It will be available in the general market via Spotify and other prescription music services on October 17, 2018. Ask your doctor if Cosmicity is right for you. WHAT IS TWICE DAILY COSMICITY? Cosmicity (Synthlotide Popiramate) capsules is an OTC normalcy-reducing medicine used to reduce the risk of moderate to severe SD (synthpop deficiency) in people with poor taste not cause by IAS (intractable asshole syndrome). IMPORTANT SAFETY INFORMATION ABOUT TWICE DAILY COSMICITY COSMICITY can cause feelings which can be serious and sometimes lead to death. Not for people with severe liver problems. Or severe first world problems. Drinking plenty of fluids may reduce your chance of dehydration. Eating plenty of food may reduce your chance of starvation. The specific way COSMICITY works is not well defined. You should be tested for PSB tolerance before starting and while taking Cosmicity. Not studied in people with severe OMD. Symptoms of a serious allergic reaction may include swelling of the face or throat, dizziness, slowing heartbeat, or enjoyment of televised golf. See our video on YouTube